NDC 16729-217-01 - SERTRALINE HYDROCHLORIDE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 16729-217
- Requested NDC
- 16729-217-01
- Package NDCs from labels
- 16729-217-10, 16729-217-15, 16729-217-01, 16729-217-16, 16729-217-43
- Manufacturer
- St. Mary's Medical Park Pharmacy
- Effective date
- 2026-06-02
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| SERTRALINE HYDROCHLORIDE - St. Mary's Medical Park Pharmacy | St. Mary's Medical Park Pharmacy | 2026-06-02 | HUMAN PRESCRIPTION DRUG LABEL |
| SERTRALINE HYDROCHLORIDE - Bryant Ranch Prepack | Bryant Ranch Prepack | 2026-05-22 | HUMAN PRESCRIPTION DRUG LABEL |
| SERTRALINE HYDROCHLORIDE - Accord Healthcare, Inc. | Intas Pharmaceuticals Ltd | Accord Healthcare, Inc. | Intas Pharmaceuticals Ltd | 2025-12-17 | HUMAN PRESCRIPTION DRUG LABEL |
| SERTRALINE HYDROCHLORIDE - Preferred Pharmaceuticals Inc. | Preferred Pharmaceuticals Inc. | 2025-09-19 | HUMAN PRESCRIPTION DRUG LABEL |
| SERTRALINE HYDROCHLORIDE - Quality Care Products, LLC | Quality Care Products, LLC | 2024-12-18 | HUMAN PRESCRIPTION DRUG LABEL |
| SERTRALINE HYDROCHLORIDE - A-S Medication Solutions | A-S Medication Solutions | 2023-05-10 | HUMAN PRESCRIPTION DRUG LABEL |
| Sertraline Hydrochloride Tablets USP | NuCare Pharmaceuticals,Inc. | 2022-07-05 | HUMAN PRESCRIPTION DRUG LABEL |
| SERTRALINE HYDROCHLORIDE - Aphena Pharma Solutions - Tennessee, LLC | Aphena Pharma Solutions - Tennessee, LLC | 2022-06-24 | HUMAN PRESCRIPTION DRUG LABEL |
| SERTRALINE HYDROCHLORIDE - RPK Pharmaceuticals, Inc. | RPK Pharmaceuticals, Inc. | 2022-03-30 | HUMAN PRESCRIPTION DRUG LABEL |
| SERTRALINE HYDROCHLORIDE - REMEDYREPACK INC. | REMEDYREPACK INC. | 2021-09-27 | HUMAN PRESCRIPTION DRUG LABEL |
| SERTRALINE HYDROCHLORIDE - Unit Dose Services | Unit Dose Services | 2021-05-20 | HUMAN PRESCRIPTION DRUG LABEL |
| SERTRALINE HYDROCHLORIDE - Preferred Pharmaceuticals Inc. | Preferred Pharmaceuticals Inc. | 2020-09-16 | HUMAN PRESCRIPTION DRUG LABEL |
| SERTRALINE HYDROCHLORIDE - Proficient Rx LP | Proficient Rx LP | 2019-11-01 | HUMAN PRESCRIPTION DRUG LABEL |
| Sertraline Hydrochloride Tablets USP | NuCare Pharmaceuticals, Inc. | 2017-07-11 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 16729-217-01 | SERTRALINE HYDROCHLORIDE | 100 in 1 BOTTLE | TABLET, FILM COATED | 100 | 19 | |
| 16729-217-10 | SERTRALINE HYDROCHLORIDE | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 19 | |
| 16729-217-15 | SERTRALINE HYDROCHLORIDE | 90 in 1 BOTTLE | TABLET, FILM COATED | 90 | 19 | |
| 16729-217-16 | SERTRALINE HYDROCHLORIDE | 500 in 1 BOTTLE | TABLET, FILM COATED | 500 | 19 | |
| 16729-217-43 | SERTRALINE HYDROCHLORIDE | 100 in 1 BOX, UNIT-DOSE | TABLET, FILM COATED | 100 | 19 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 16729-217-15 | EA - Each | 16729-217 | eb3a47d7-6880-4830-8c75-df42367fdf09 | 1 | 2017-03-06 |
| 16729-217-16 | EA - Each | 16729-217 | cf3d11b6-fdea-49ef-94bc-bcd3a4bd91fd | 1 | 2017-03-06 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sertraline Hydrochloride | SERTRALINE HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | e815c67d-951c-4cb3-a840-f0b493b97da1 | 2020-06-23 | Boxed warning, Warnings, Adverse reactions | 312938 UTI8907Y6X |
| a5b487d8-7210-a25d-e053-2995a90a5183 | 540dddc1-000b-67bc-e054-00144ff88e88 | 2020-05-15 | Boxed warning, Warnings, Adverse reactions | 540dddc1-000b-67bc-e054-00144ff88e88 | ||
| Sertraline Hydrochloride | SERTRALINE HYDROCHLORIDE | Proficient Rx LP | 787a683a-091c-4908-a643-ecbc8fd467eb | 2020-02-01 | Boxed warning, Warnings, Adverse reactions | 312938 UTI8907Y6X |
| Sertraline Hydrochloride | SERTRALINE HYDROCHLORIDE | Proficient Rx LP | 00179766-980b-44b0-99d3-1fee2bb27e37 | 2019-11-01 | Boxed warning, Warnings, Adverse reactions | 312940 UTI8907Y6X |
| Sertraline Hydrochloride | SERTRALINE HYDROCHLORIDE | Proficient Rx LP | 551d5946-00df-4608-96a2-b29f0ef93ba0 | 2019-11-01 | Boxed warning, Warnings, Adverse reactions | 312941 UTI8907Y6X |
| SERTRALINE HYDROCHLORIDE | SERTRALINE HYDROCHLORIDE | Proficient Rx LP | 6b532e6a-b040-4a10-a242-fb6d8dfc0852 | 2019-11-01 | Boxed warning, Warnings, Adverse reactions | ANDA202825 71205-047-30 71205-047-90 71205-028-90 71205-047-60 71205-028-60 71205-028-30 71205-028 71205-047 312938 312941 cbf2683a-b8ea-49b3-a0a0-63c69d70f2fb 6b532e6a-b040-4a10-a242-fb6d8dfc0852 UTI8907Y6X |
| No7 Perfect and Perfect Intense Advanced All in One Foundation SPF 50 Cool Vanilla | OCTINOXATE, TITANIUM DIOIXIDE, OCTISALATE | BCM Cosmetique SAS | d701c221-9f68-47ff-b766-2f4f1998649f | 2019-10-08 | Warnings | 15FIX9V2JP |
| No7 Perfect and Perfect Intense Advanced All in One Foundation SPF 50 Amber | OCTINOXATE, TITANIUM DIOIXIDE, OCTISALATE | BCM Cosmetique SAS | 7f5e6872-4d26-410e-8afe-16a016f9a399 | 2019-10-08 | Warnings | 15FIX9V2JP |
| No7 Perfect and Perfect Advanced All in One Foundation SPF 50 Warm Ivory | OCTINOXATE, TITANIUM DIOIXIDE, OCTISALATE | BCM Cosmetique SAS | 1124ba7d-a328-409b-8c88-e74bb3e501f5 | 2019-10-08 | Warnings | 15FIX9V2JP |
| No7 Perfect and Perfect Advanced All in One Foundation SPF 50 Honey | OCTINOXATE, TITANIUM DIOIXIDE, OCTISALATE | BCM Cosmetique SAS | 9c407dc7-fcde-4660-9a06-57bd8a6b867d | 2019-10-08 | Warnings | 15FIX9V2JP |
| No7 Perfect and Perfect Intense Advanced All in One Foundation SPF 50 Chestnut | OCTINOXATE, TITANIUM DIOIXIDE, OCTISALATE | BCM Cosmetique SAS | f07e8bb2-30ae-4337-ad60-84f55f2ff354 | 2019-10-08 | Warnings | 15FIX9V2JP |
| CLE CCC Golden Medium Deep | TITANIUM DIOXIDE, OCTINOXATE, OCTISALATE | KW ABSC, INC. | b7a4847f-b84d-4f36-8787-104eccd838a0 | 2018-12-03 | Warnings | 15FIX9V2JP |
| CLE CCC Warm Medium Deep | TITANIUM DIOXIDE, OCTINOXATE, OCTISALATE | KW ABSC, INC. | 229c20a3-6288-4ac3-9098-6d1622e906ab | 2018-11-29 | Warnings | 15FIX9V2JP |
| CLE CCC Warm Medium Light | TITANIUM DIOXIDE, OCTINOXATE, OCTISALATE | KW ABSC, INC. | fc90fb8a-44b3-47cd-882e-94ed324ed389 | 2018-11-27 | Warnings | 15FIX9V2JP |
| CLE CCC Warm Medium | TITANIUM DIOXIDE, OCTINOXATE, OCTISALATE | KW ABSC, INC. | b585f216-4234-47c5-9a6b-8b133ef48aae | 2018-11-27 | Warnings | 15FIX9V2JP |
| CLE CCC Warm Light | TITANIUM DIOXIDE, OCTINOXATE, OCTISALATE | KW ABSC, INC. | 14891e26-b3b6-4545-99b1-da914b7f5629 | 2018-11-24 | Warnings | 15FIX9V2JP |
| Additox | TRIFOLIUM PRATENSE, XANTHOXYLUM FRAXINEUM, PHYTOLACCA DECANDRA, ARSENICUM ALBUM, BELLADONNA, CHELIDONIUM MAJUS, LYCOPODIUM CLAVATUM, PHOSPHORICUM ACIDUM, ASPARTAME, BENZALKONIUM CHLORIDE, FORMALINUM, METHYLENE CHLORIDE, METHYLPARABEN, PROPYLPARABEN, SODIUM BENZOATE, SODIUM CITRATE, TITANIUM DIOXIDE, ZINCUM OXYDATUM | BioActive Nutritional, Inc. | 319ee2fe-58e3-495e-bf0d-df201f6fbb1c | 2018-07-18 | Warnings | 15FIX9V2JP |
| Your Name Cosmetics Mineral Sheet Tint Broad Spectrum SPF 20 | YOUR NAME COSMETICS MINERAL SHEET TINT BROAD SPECTRUM SPF 20 | Mana Products | 657d5090-30a8-46d0-879d-469178aa234d | 2018-01-25 | Warnings | 15FIX9V2JP |
| Mineral Sunscreen Moisturizer Broad Spectrum SPF 20 | ZINC OXIDE AND TITANIUM DIOXIDE | Allure Labs, Inc | 316c2132-ab81-47f6-8e80-71e9252a2663 | 2017-12-12 | Warnings | 15FIX9V2JP |
| Mineral Sunscreen Broad Spectrum SPF 45 | ZINC OXIDE AND TITANIUM DIOXIDE | Allure Labs, Inc | 96d2d0f1-dbde-4b66-9b2c-9d07f7547066 | 2017-12-11 | Warnings | 15FIX9V2JP |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.